3,4,5-trisubstituted-1,2,4-triazoles and 3,4,5-trisubstituted-3-thio-1,2,4-triazoles and uses thereof
Abstract:
The present disclosure describes novel compounds that are somatostatin receptor type 4 agonists.
Information query
Patent Agency Ranking
0/0